Global Advanced Wound Care Market will be worth USD 20.7 billion by 2024 – New market report by Data Bridge Market Research

December 13 19:32 2016

“Global Advanced Wound Care Market is expected to grow at 7.6% in the forecast period 2017 to 2024”
Global Advanced Wound Care Market, By Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare), By Distribution Channel (Direct Tenders Public, Retail Private), By Geography – Industry Trends and Forecast to 2024

Global Advanced Wound Care Market is expected to reach USD 20.7 billion by 2024, from USD 11.6 billion in 2016 growing at a CAGR of 7.6% during the forecast period of 2017 to 2024.

Global Advanced Wound Care Market is segmented based on type, product type, application, end-user, distribution channel and geography.

For Sample Report: Global Advanced Wound Care Market – Industry Trends and Forecast to 2024

On the basis of type the advanced wound care market is segmented into dressings, biologics and therapy devices.

To read more about the scope and findings of this report visit: Global Topical Drug Delivery Market is poised to grow at 9.2% till 2024

Based on product type the market is further segmented into foam dressings, film dressings, hydrogels, alginates, wound contact layers and super absorbent dressings. The advanced wound care biologics market segment is sub-segment into allografts, synthetic skin grafts, xenografts, and growth factors. The Therapy devices segment is further classified on the basis of product type into NPWT devices, pressure relief devices, hyperbaric oxygen chambers (HBOT), wound debridement.

On the basis of application the advanced wound care devices market is segmented into surgical wounds, diabetic ulcers, pressure ulcers, venous ulcers, burns and others.

Based on end-user the market is segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.

KEY PLAYERS OPERATING IN GLOBAL ADVANCED WOUND CARE MARKET:

  • 3M
  • Smith and Nephew
  • Medtronic
  • Acelity L.P., Inc.
  • Becton Dickinson and Company
  • Molyncke Healthcare AB
  • Convatec, Inc.
  • Baxter
  • Coloplast
  • Ethicon, Inc.
  • Hollister Incorporated
  • Integra Lifesciences Corporation
  • Derma Sciences, Inc.
  • Spiracur, Inc.
  • Medline Industries
  • Mimedx, Inc.
  • Organogenesis, Inc.
  • Talley Group
  • BSN Medical
  • Devon Medical Products
  • Human Biosciences, Inc.
  • Cardinal Health
  • B.Braun Melsungen AG
  • Paul Hartmann Limited

To Browse Full Report and Pricing: Global Advanced Wound Care Market – Industry Trends and Forecast to 2024

Table of Content:

1 INTRODUCTION

   1.1. OVERVIEW OF THE GLOBAL ADVANCED WOUND CARE MARKET

   1.2. MARKET SEGMENTATION & COVERAGE

           1.2.1. CURRENCY AND PRICING

           1.2.2. LIMITATION

           1.2.3. STAKEHOLDERS

2 RESEARCH METHODOLOGY

   2.1. KEY TAKEAWAYS

   2.2. ARRIVING AT THE GLOBAL ADVANCED WOUND CARE MARKET SIZE

           2.2.1. MARKET CRACKDOWN APPROACH

           2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

           2.2.3. DATA TRIANGULATION

           2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

           2.2.5. PRODUCT PIPELINE ANALYSIS

           2.2.6. PORTER’S FIVE FORCES MATRIX

   2.3. GLOBAL ADVANCED WOUND CARE MARKET: RESEARCH SNAPSHOT

   2.4. ASSUMPTIONS

3 MARKET LANDSCAPE SUMMARY

4 PREMIUM INSIGHTS

   4.1. OVERVIEW

   4.2. GLOBAL ADVANCED WOUND CARE MARKET: KEY PRIMARY INSIGHTS

   4.3. MARKET OVERVIEW

           4.3.1. DRIVERS

                      4.3.1.1. INCREASING ACCEPTANCE OF WOUND CARE BIOLOGICS

                      4.3.1.2. TECHNOLOGICALLY BENEFICIAL

                      4.3.1.3. INCREASING POOL OF AGING POPULATION AND DIABETES

                      4.3.1.4. INCREASING DEMAND FOR MODERN HEALTHCARE IN ASIA

                      4.3.1.5. RISING ACCEPTANCE OF HOME HEALTHCARE

           4.3.2. RESTRAINTS

           4.3.3. OPPURTUNITIES

           4.3.4. THREATS

   4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5 ADVANCED WOUND CARE MARKET, BY TYPE

    5.1. OVERVIEW

    5.2. ADVANCED WOUND CARE DRESSINGS, BY PRODUCT TYPE

            5.2.1. FILM DRESSINGS

            5.2.2. FOAM DRESSINGS

            5.2.3. HYDROGELS

            5.2.4. ALGINATES

            5.2.5. WOUND CONTACT LAYERS

            5.2.6. SUPER ABSORBENT DRESSINGS

    5.3. ADVANCED WOUND CARE BIOLOGICS, BY PRODUCT TYPE

            5.3.1. ALLOGRAFTS

            5.3.2. SYNTHETIC SKIN GRAFTS

            5.3.3. XENOGRAFTS

            5.3.4. GROWTH FACTORS

                       5.3.4.1. PLATELET-DERIVED GROWTH FACTOR (PDGF)

                       5.3.4.2. PLATELET RICH PLASMA (PRP)

                       5.3.4.3. EPIDERMAL GROWTH FACTORS (EGF)

                       5.3.4.4. BASIC FIBROBLAST GROWTH FACTOR (BFGF)

                       5.3.4.5. GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF)

                       5.3.4.6. TALACTOFERRIN ALFA

                       5.3.4.7. THROMBIN PEPTIDE (TP508)

                       5.3.4.8. KERATINOCYTE GROWTH FACTOR (KGF)

   5.4. ADVANCED WOUND CARE THERAPY DEVICES, BY PRODUCT TYPE

           5.4.1. NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT)

                      5.4.1.1. STAND-ALONE NPWT DEVICES

                      5.4.1.2. PORTABLE NPWT DEVICES

                      5.4.1.3. DISPOSABLE NPWT DEVICES

           5.4.2. PRESSURE RELIEF DEVICES (PRD)

                       5.4.2.1. MATRESSES

                       5.4.2.2. BEDS

           5.4.3. HYBERBARIC OXYGEN CHAMBERS

                       5.4.3.1. MONOPLACE

                       5.4.3.2. MULTIPLACE

                       5.4.3.3. TOPICAL

           5.4.4. WOUND DEBRIDEMENT DEVICES

                       5.4.4.1. HYDROSURGICAL

                       5.4.4.2. MECHANICAL

                       5.4.4.3. ULTRASOUND

                       5.4.4.4. OTHERS

           5.4.5. PHYSICAL THERAPIES

                      5.4.5.1. LASER THERAPY

                      5.4.5.2. ELECTRICAL STIMULATION

                      5.4.5.3. EXTERNAL SHOCK WAVE THERAPIES (ESWT)

                      5.4.5.4. SALINE MIST THERAPY

6 ADVANCED WOUND CARE MARKET, BY WOUND TYPE

   6.1. OVERVIEW

   6.2. SURGICAL WOUNDS

   6.3. DIABETIC ULCERS

   6.4. PRESSURE ULCERS

   6.5. VENOUS ULCERS

   6.6. BURNS

   6.7. OTHERS

7 ADVANCED WOUND CARE MARKET, BY END-USER

    7.1. OVERVIEW

    7.2. HOSPITALS

    7.3. WOUND CARE CENTERS

    7.4. AMBULATORY CENTERS

    7.5. HOME HEALTHCARE

    7.6. CLINICS

    7.6. COMMUNITY HEALTHCARE

8 ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

    8.1. OVERVIEW

    8.2. DIRECT TENDERS

    8.3. RETAIL

9 ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

    9.1. COUNTRYWISE ADVANCED WOUND CARE MARKET,

    (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY

     COUNTRY)

            9.1.1. NORTH AMERICA

                       9.1.1.1. U.S.

                       9.1.1.2. CANADA

                       9.1.1.3. MEXICO

            9.1.2. EUROPE

                       9.1.2.1. GERMANY

                       9.1.2.2. FRANCE

                       9.1.2.3. U.K.

                       9.1.2.4. ITALY

                       9.1.2.5. SPAIN

                       9.1.2.6. RUSSIA

                       9.1.2.7. TURKEY

                       9.1.2.8. BELGIUM

                       9.1.2.9. NETHERLANDS

                       9.1.2.10. SWITZERLAND

                       9.1.2.11. REST OF EUROPE

            9.1.3. ASIA-PACIFIC (APAC)

                       9.1.3.1. JAPAN

                       9.1.3.2. CHINA

                       9.1.3.3. SOUTH KOREA

                       9.1.3.4. INDIA

                       9.1.3.5. AUSTRALIA

                       9.1.3.6. SINGAPORE

                       9.1.3.7. THAILAND

                       9.1.3.8. MALAYSIA

                       9.1.3.9. INDONESIA

                       9.1.3.10. PHILIPPINES

                       9.1.3.11. REST OF APAC

            9.1.4. LATIN AMERICA

                       9.1.4.1. BRAZIL

                       9.1.4.2. REST OF LATIN AMERICA

           9.1.5. MIDDLE EAST AND AFRICA

                       9.1.5.1. SOUTH AFRICA

                       9.1.5.2. REST OF MIDDLE EAST AND AFRICA

      9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10 ADVANCED WOUND CARE MARKET: COMPETITIVE LANDSCAPE

      10.1. GLOBAL ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS

      10.2. U.S. ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS

      10.3. EUROPE ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS

      10.4. APAC ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS

      10.5. SOUTH AMERICA ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS

      10.6. MEA ADVANCED WOUND CARE MARKET: COMPANY SHARE ANALYSIS

      10.7. MERGERS & ACQUISITIONS

      10.8. NEW PRODUCT DEVELOPMENT & APPROVALS

      10.9. EXPANSIONS

      10.10. REGULATORY CHANGES

      10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11 ADVANCED WOUND CARE MARKET, COMPANY PROFILES

      11.1 3M

               11.1.1 COMPANY OVERVIEW

               11.1.2 SWOT ANALYSIS

               11.1.3 REVENUE ANALYSIS

               11.1.4 PRODUCT PORTFOLIO

               11.1.5 RECENT DEVELOPEMENTS

               11.1.6 DATA BRIDGE ANALYSIS

      11.2 SMITH AND NEPHEW

               11.2.1 COMPANY OVERVIEW

               11.2.2 SWOT ANALYSIS

               11.2.3 REVENUE ANALYSIS

               11.2.4 PRODUCT PORTFOLIO

               11.2.5 RECENT DEVELOPEMENTS

               11.2.6 DATA BRIDGE ANALYSIS

       11.3 MEDTRONIC

                11.3.1 COMPANY OVERVIEW

                11.3.2 SWOT ANALYSIS

                11.3.3 REVENUE ANALYSIS

                11.3.4 PRODUCT PORTFOLIO

                11.3.5 RECENT DEVELOPEMENTS

                11.3.6 DATA BRIDGE ANALYSIS

       11.4 ACELITY L.P. INC.

                11.4.1 COMPANY OVERVIEW

                11.4.2 SWOT ANALYSIS

                11.4.3 REVENUE ANALYSIS

                11.4.4 PRODUCT PORTFOLIO

                11.4.5 RECENT DEVELOPEMENTS

                11.4.6 DATA BRIDGE ANALYSIS

       11.5 BECTON, DICKINSON AND COMPANY

                11.5.1 COMPANY OVERVIEW

                11.5.2 SWOT ANALYSIS

                11.5.3 REVENUE ANALYSIS

                11.5.4 PRODUCT PORTFOLIO

                11.5.5 RECENT DEVELOPEMENTS

                11.5.6 DATA BRIDGE ANALYSIS

        11.6 MOLYNCKE HEALTH CARE AB

                 11.6.1 COMPANY OVERVIEW

                 11.6.2 SWOT ANALYSIS

                 11.6.3 REVENUE ANALYSIS

                 11.6.4 PRODUCT PORTFOLIO

                 11.6.5 RECENT DEVELOPEMENTS

                 11.6.6 DATA BRIDGE ANALYSIS

        11.7 CONVATEC INC.

                 11.7.1 COMPANY OVERVIEW

                 11.7.2 SWOT ANALYSIS

                 11.7.3 REVENUE ANALYSIS

                 11.7.4 PRODUCT PORTFOLIO

                 11.7.5 RECENT DEVELOPEMENTS

                 11.7.5 DATA BRIDGE ANALYSIS

        11.8 BAXTER

                 11.8.1 COMPANY OVERVIEW

                 11.8.2 SWOT ANALYSIS

                 11.8.3 REVENUE ANALYSIS

                 11.8.4 PRODUCT PORTFOLIO

                 11.8.5 RECENT DEVELOPEMENTS

                 11.8.6 DATA BRIDGE ANALYSIS

        11.9 COLOPLAST

                 11.9.1 COMPANY OVERVIEW

                 11.9.2 SWOT ANALYSIS

                 11.9.3 REVENUE ANALYSIS

                 11.9.4 PRODUCT PORTFOLIO

                 11.9.5 RECENT DEVELOPEMENTS

                 11.9.6 DATA BRIDGE ANALYSIS

        11.10 ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)

                  11.10.1 COMPANY OVERVIEW

                  11.10.2 SWOT ANALYSIS

                  11.10.3 REVENUE ANALYSIS

                  11.10.4 PRODUCT PORTFOLIO

                  11.10.5 RECENT DEVELOPEMENTS

                  11.10.5 DATA BRIDGE ANALYSIS

         11.11 HOLLISTER INCORPORATED

                  11.11.1 COMPANY OVERVIEW

                  11.11.2 SWOT ANALYSIS

                  11.11.3 REVENUE ANALYSIS

                  11.11.4 PRODUCT PORTFOLIO

                  11.11.5 RECENT DEVELOPEMENTS

                  11.11.5 DATA BRIDGE ANALYSIS

         11.12 INTEGRA LIFESCIENCES CORPORATION

                    11.12.1 COMPANY OVERVIEW

                    11.12.2 SWOT ANALYSIS

                    11.12.3 REVENUE ANALYSIS

                    11.12.4 PRODUCT PORTFOLIO

                    11.12.5 RECENT DEVELOPEMENTS

                    11.12.5 DATA BRIDGE ANALYSIS

         11.13 DERMA SCIENCES INC.

                    11.13.1 COMPANY OVERVIEW

                    11.13.2 SWOT ANALYSIS

                    11.13.3 REVENUE ANALYSIS

                     11.13.4 PRODUCT PORTFOLIO

                     11.13.5 RECENT DEVELOPEMENTS

                     11.13.5 DATA BRIDGE ANALYSIS

          11.14 SPIRACUR, INC.

                     11.14.1 COMPANY OVERVIEW

                     11.14.2 SWOT ANALYSIS

                     11.14.3 REVENUE ANALYSIS

                     11.14.4 PRODUCT PORTFOLIO

                     11.14.5 RECENT DEVELOPEMENTS

                     11.14.5 DATA BRIDGE ANALYSIS

          11.15 MEDLINE INDUSTRIES

                      11.15.1 COMPANY OVERVIEW

                      11.15.2 SWOT ANALYSIS

                      11.15.3 REVENUE ANALYSIS

                      11.15.4 PRODUCT PORTFOLIO

                      11.15.5 RECENT DEVELOPEMENTS

                      11.15.5 DATA BRIDGE ANALYSIS

           11.16 MIMEDX GROUP

                       11.16.1 COMPANY OVERVIEW

                       11.16.2 SWOT ANALYSIS

                       11.16.3 REVENUE ANALYSIS

                       11.16.4 PRODUCT PORTFOLIO

                       11.16.5 RECENT DEVELOPEMENTS

                       11.16.5 DATA BRIDGE ANALYSIS

           11.17 ORGANOGENESIS, INC.

                       11.17.1 COMPANY OVERVIEW

                       11.17.2 SWOT ANALYSIS

                       11.17.3 REVENUE ANALYSIS

                       11.17.4 PRODUCT PORTFOLIO

                       11.17.5 RECENT DEVELOPEMENTS

                       11.17.5 DATA BRIDGE ANALYSIS

            11.18 TALLEY GROUP

                       11.18.1 COMPANY OVERVIEW

                       11.18.2 SWOT ANALYSIS

                       11.18.3 REVENUE ANALYSIS

                       11.18.4 PRODUCT PORTFOLIO

                       11.18.5 RECENT DEVELOPEMENTS

                       11.18.5 DATA BRIDGE ANALYSIS

            11.19 BSN MEDICAL

                       11.19.1 COMPANY OVERVIEW

                       11.19.2 SWOT ANALYSIS

                       11.19.3 REVENUE ANALYSIS

                       11.19.4 PRODUCT PORTFOLIO

                       11.19.5 RECENT DEVELOPEMENTS

                       11.19.5 DATA BRIDGE ANALYSIS

            11.20 DEVON MEDICAL PRODUCTS

                       11.20.1 COMPANY OVERVIEW

                       11.20.2 SWOT ANALYSIS

                       11.20.3 REVENUE ANALYSIS

                       11.20.4 PRODUCT PORTFOLIO

                       11.20.5 RECENT DEVELOPEMENTS

                       11.20.5 DATA BRIDGE ANALYSIS

            11.21 HUMAN BIOSCIENCES, INC.

                       11.21.1 COMPANY OVERVIEW

                       11.21.2 SWOT ANALYSIS

                       11.21.3 REVENUE ANALYSIS

                       11.21.4 PRODUCT PORTFOLIO

                       11.21.5 RECENT DEVELOPEMENTS

                       11.21.5 DATA BRIDGE ANALYSIS

            11.22 B.BRAUN MELSUNGEN AG

                       11.22.1 COMPANY OVERVIEW

                       11.22.2 SWOT ANALYSIS

                       11.22.3 REVENUE ANALYSIS

                       11.22.4 PRODUCT PORTFOLIO

                       11.22.5 RECENT DEVELOPEMENTS

                       11.22.5 DATA BRIDGE ANALYSIS

            11.23 CARDINAL HEALTH

                        11.23.1 COMPANY OVERVIEW

                        11.23.2 SWOT ANALYSIS

                        11.23.3 REVENUE ANALYSIS

                        11.23.4 PRODUCT PORTFOLIO

                        11.23.5 RECENT DEVELOPEMENTS

                        11.23.5 DATA BRIDGE ANALYSIS

            11.24 PAUL HARTMANN LIMITED

                       11.24.1 COMPANY OVERVIEW

                       11.24.2 SWOT ANALYSIS

                       11.24.3 REVENUE ANALYSIS

                       11.24.4 PRODUCT PORTFOLIO

                       11.24.5 RECENT DEVELOPEMENTS

                       11.24.5 DATA BRIDGE ANALYSIS

12 APPENDIX

      12.1. EPIDEMIOLOGY DATA

      12.2. SOURCES AND BIBLIOGRAPHY

      12.3. RELATED REPORTS

      12.4. A GLIMSE OF DATA BRIDGE MARKET RESEARCH FACTBOOK

13 ABOUT DATA BRIDGE MARKET RESEARCH

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

North America Advanced Wound Care Market – Trends and Forecast to 2022

By Product Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Surgical Centers, Other Healthcare Providers), By Geography (U.S., Canada, Mexico) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-advanced-wound-care-market/

  Categories: